An Updated List of COVID-19 Clinical Trials Outside the US

Clinical Trials Outside the United States

*Last updated on 4/10/2020

Click here for the list of trials inside the U.S.

NCT04330300: Coronavirus ACEi/ARB Investigation
Study Type: Prevention
Study Phase: 4
Status: Recruiting
Enrollment: 2414
Start: 3/30/2020
Finish: 1/31/2021

NCT04334629: LIBA Trial in COVID-19
Study Type: Treatment
Study Phase: 4
Status: Not yet recruiting
Enrollment: 230
Start: 4/6/2020
Finish: 8/5/2020

NCT04331600: ChloroQUine As antiviRal treAtmeNT In coroNavirus infEction 2020
Study Type: Treatment
Study Phase: 4
Status: Not yet recruiting
Enrollment: 400
Start: 4/6/2020
Finish: 9/30/2020

NCT04316377: Norwegian Coronavirus Disease 2019 Study
Study Type: Treatment
Study Phase: 4
Status: Recruiting
Enrollment: 202
Start: 3/25/2020
Finish: 4/1/2021

NCT04341493: Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19
Study Type: Treatment
Study Phase: 4
Status: Recruiting
Enrollment: 86
Start: 4/6/2020
Finish: 8/30/2020

NCT04252885: The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection
Study Type: Treatment
Study Phase: 4
Status: Recruiting
Enrollment: 125
Start: 1/28/2020
Finish: 5/30/2020

NCT04286503: The Clinical Study of Carrimycin on Treatment Patients With COVID-19
Study Type: Treatment
Study Phase: 4
Status: Not yet recruiting
Enrollment: 520
Start: 2/23/2020
Finish: 2/28/2021

NCT04308317: Tetrandrine Tablets Used in the Treatment of COVID-19
Study Type: Treatment
Study Phase: 4
Status: Enrolling by invitation
Enrollment: 60
Start: 3/5/2020
Finish: 3/1/2021

NCT04291729: Evaluation of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of Novel Coronavirus Infection
Study Type: Treatment
Study Phase: 4
Status: Completed
Enrollment: 11
Start: 2/17/2020
Finish: 3/19/2020

NCT04260594: Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus
Study Type: Treatment
Study Phase: 4
Status: Not yet recruiting
Enrollment: 380
Start: 2/7/2020
Finish: 7/1/2020

NCT04326920: Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC)
Study Type: Treatment
Study Phase: 4
Status: Recruiting
Enrollment: 80
Start: 3/24/2020
Finish: 10/31/2020

NCT04334928: Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel
Study Type: Prevention
Study Phase: 3
Status: Active, not recruiting
Enrollment: 4000
Start: 4/1/2020
Finish: 6/30/2020

NCT04342156: Safety And Efficacy Of Hydroxychloroquine As COVID-19 Prophylaxis For At-Risk Population (SHARP): A Cluster Randomized Controlled Trial
Study Type: Prevention
Study Phase: 3
Status: Not yet recruiting
Enrollment: 3000
Start: 4/1/2020
Finish: 8/1/2020

NCT04318015: Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial)
Study Type: Prevention
Study Phase: 3
Status: Not yet recruiting
Enrollment: 400
Start: 4/1/2020
Finish: 12/31/2020

NCT04320238: Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical Staff
Study Type: Prevention
Study Phase: 3
Status: Recruiting
Enrollment: 2944
Start: 1/21/2020
Finish: 5/1/2020

NCT04321174: COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir
Study Type: Prevention
Study Phase: 3
Status: Not yet recruiting
Enrollment: 1220
Start: 3/30/2020
Finish: 3/31/2021

NCT04338698: Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT
Study Type: Treatment
Study Phase: 3
Status: Not yet recruiting
Enrollment: 500
Start: 4/7/2020
Finish: 9/1/2020

NCT04315896: Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial)
Study Type: Treatment
Study Phase: 3
Status: Not yet recruiting
Enrollment: 500
Start: 3/23/2020
Finish: 10/31/2020

NCT04342221: Hydroxychloroquine for COVID-19
Study Type: Treatment
Study Phase: 3
Status: Recruiting
Enrollment: 220
Start: 3/29/2020
Finish: 3/1/2021

NCT04325893: Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease
Study Type: Treatment
Study Phase: 3
Status: Recruiting
Enrollment: 1300
Start: 4/1/2020
Finish: 9/1/2020

NCT04315948: Trial of Treatments for COVID-19 in Hospitalized Adults
Study Type: Treatment
Study Phase: 3
Status: Recruiting
Enrollment: 3100
Start: 3/22/2020
Finish: 3/1/2023

NCT04329195: ACE Inhibitors or ARBs Discontinuation in Context of SARS-CoV-2 Pandemic
Study Type: Treatment
Study Phase: 3
Status: Not yet recruiting
Enrollment: 554
Start: 4/1/2020
Finish: 5/1/2020

NCT04323345: Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus
Study Type: Treatment
Study Phase: 3
Status: Not yet recruiting
Enrollment: 1000
Start: 3/25/2020
Finish: 4/25/2020

NCT04339816: Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial
Study Type: Treatment
Study Phase: 3
Status: Not yet recruiting
Enrollment: 240
Start: 4/20/2020
Finish: 12/31/2021

NCT04282902: A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection
Study Type: Treatment
Study Phase: 3
Status: Recruiting
Enrollment: 294
Start: 2/4/2020
Finish: 4/30/2020

NCT04261517: Efficacy and Safety of Hydroxychloroquine for Treatment of Pneumonia Caused by 2019-nCoV ( HC-nCoV )
Study Type: Treatment
Study Phase: 3
Status: Completed
Enrollment: 30
Start: 2/6/2020
Finish: 2/25/2020

NCT04252274: Efficacy and Safety of Darunavir and Cobicistat for Treatment of Pneumonia Caused by 2019-nCoV
Study Type: Treatment
Study Phase: 3
Status: Recruiting
Enrollment: 30
Start: 1/30/2020
Finish: 8/31/2020

NCT04323332: Traditional Chinese Medicine for Severe COVID-19
Study Type: Treatment
Study Phase: 3
Status: Not yet recruiting
Enrollment: 50
Start: 3/1/2020
Finish: 3/1/2020

NCT04324463: Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial
Study Type: Treatment
Study Phase: 3
Status: Not yet recruiting
Enrollment: 1500
Start: 4/1/2020
Finish: 9/30/2020

NCT04322123: Safety and Efficacy of Hydroxychloroquine Associated With Azythromycin in SARS-Cov-2 Virus
Study Type: Treatment
Study Phase: 3
Status: Recruiting
Enrollment: 630
Start: 4/6/2020
Finish: 8/30/2020

NCT04321278: Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II)
Study Type: Treatment
Study Phase: 3
Status: Recruiting
Enrollment: 440
Start: 3/28/2020
Finish: 8/30/2020

NCT04327401: COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III
Study Type: Treatment
Study Phase: 3
Status: Not yet recruiting
Enrollment: 290
Start: 4/1/2020
Finish: 8/30/2020

NCT04330638: Treatment of COVID-19 Patients With Anti-interleukin Drugs
Study Type: Treatment
Study Phase: 3
Status: Recruiting
Enrollment: 342
Start: 4/1/2020
Finish: 9/1/2020

NCT04327206: BCG Vaccination to Protect Healthcare Workers Against COVID-19
Study Type: Vaccine
Study Phase: 3
Status: Recruiting
Enrollment: 4170
Start: 3/30/2020
Finish: 10/30/2020

NCT04321616: The Efficacy of Different Anti-viral Drugs in (Severe Acute Respiratory Syndrome-Corona Virus-2) SARS-CoV-2
Study Type: Treatment
Study Phase: 2|3
Status: Not yet recruiting
Enrollment: 700
Start: 3/26/2020
Finish: 8/1/2020

NCT04322344: Escin in Patients With Covid-19 Infection
Study Type: Treatment
Study Phase: 2|3
Status: Recruiting
Enrollment: 120
Start: 3/23/2020
Finish: 6/30/2020

NCT04323592: Efficacy of Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome
Study Type: Treatment
Study Phase: 2|3
Status: Recruiting
Enrollment: 104
Start: 3/23/2020
Finish: 5/20/2020

NCT04327388: Sarilumab COVID-19
Study Type: Treatment
Study Phase: 2|3
Status: Recruiting
Enrollment: 300
Start: 3/29/2020
Finish: 7/1/2020

NCT04324073: Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI
Study Type: Treatment
Study Phase: 2|3
Status: Recruiting
Enrollment: 240
Start: 3/27/2020
Finish: 3/27/2021

NCT04332835: Convalescent Plasma for Patients With COVID-19: A Randomized, Open Label, Parallel, Controlled Clinical Study
Study Type: Treatment
Study Phase: 2|3
Status: Not yet recruiting
Enrollment: 80
Start: 4/1/2020
Finish: 8/31/2020

NCT04319900: Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia
Study Type: Treatment
Study Phase: 2|3
Status: Recruiting
Enrollment: 150
Start: 3/5/2020
Finish: 4/30/2020

NCT04275414: Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia
Study Type: Treatment
Study Phase: 2|3
Status: Recruiting
Enrollment: 20
Start: 2/15/2020
Finish: 4/1/2020

NCT04244591: Glucocorticoid Therapy for Novel CoronavirusCritically Ill Patients With Severe Acute Respiratory Failure
Study Type: Treatment
Study Phase: 2|3
Status: Recruiting
Enrollment: 80
Start: 1/26/2020
Finish: 4/25/2020

NCT04332666: Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial
Study Type: Treatment
Study Phase: 2|3
Status: Not yet recruiting
Enrollment: 60
Start: 3/31/2020
Finish: 5/30/2020

NCT04337918: Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection
Study Type: Prevention/Treatment
Study Phase: 2
Status: Not yet recruiting
Enrollment: 200
Start: 4/6/2020
Finish: 7/31/2020

NCT04335071: Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19)
Study Type: Treatment
Study Phase: 2
Status: Not yet recruiting
Enrollment: 100
Start: 4/1/2020
Finish: 10/1/2020

NCT04335305: Checkpoint Blockade in COVID-19 Pandemic
Study Type: Treatment
Study Phase: 2
Status: Not yet recruiting
Enrollment: 24
Start: 3/30/2020
Finish: 5/15/2020

NCT04307693: Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19)
Study Type: Treatment
Study Phase: 2
Status: Recruiting
Enrollment: 150
Start: 3/11/2020
Finish: 5/1/2020

NCT04330586: A Trial of Ciclesonide in Adults With Mild COVID-19
Study Type: Treatment
Study Phase: 2
Status: Not yet recruiting
Enrollment: 141
Start: 4/1/2020
Finish: 6/30/2020

NCT04322565: Colchicine Efficacy in COVID-19 Pneumonia
Study Type: Treatment
Study Phase: 2
Status: Not yet recruiting
Enrollment: 100
Start: 4/1/2020
Finish: 5/30/2020

NCT04333472: Piclidenoson for Treatment of COVID-19
Study Type: Treatment
Study Phase: 2
Status: Not yet recruiting
Enrollment: 40
Start: 4/6/2020
Finish: 6/6/2020

NCT04276688: Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment
Study Type: Treatment
Study Phase: 2
Status: Recruiting
Enrollment: 70
Start: 2/10/2020
Finish: 1/31/2022

NCT04326790: The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention
Study Type: Treatment
Study Phase: 2
Status: Not yet recruiting
Enrollment: 180
Start: 4/6/2020
Finish: 8/31/2020

NCT04339712: Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction
Study Type: Treatment
Study Phase: 2
Status: Not yet recruiting
Enrollment: 20
Start: 4/6/2020
Finish: 4/1/2022

NCT04331808: CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI)
Study Type: Treatment
Study Phase: 2
Status: Not yet recruiting
Enrollment: 240
Start: 3/31/2020
Finish: 3/31/2021

NCT04341584: CORIMUNO-ANA: TRIAL EVALUATING EFFICACY OF ANAKINRA IN PATIENTS WITH COVID-19 INFECTION, NESTED IN THE CORIMUNO-19 COHORT
Study Type: Treatment
Study Phase: 2
Status: Not yet recruiting
Enrollment: 240
Start: 4/1/2020
Finish: 5/1/2020

NCT04322773: Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure
Study Type: Treatment
Study Phase: 2
Status: Recruiting
Enrollment: 200
Start: 4/5/2020
Finish: 6/1/2021

NCT04322396: Proactive Prophylaxis With Azithromycin and Chloroquine in Hospitalized Patients With COVID-19
Study Type: Treatment
Study Phase: 2
Status: Recruiting
Enrollment: 226
Start: 4/6/2020
Finish: 10/31/2020

NCT04332380: Convalescent Plasma for Patients With COVID-19: A Pilot Study
Study Type: Treatment
Study Phase: 2
Status: Not yet recruiting
Enrollment: 10
Start: 4/1/2020
Finish: 8/31/2020

NCT04306393: Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19
Study Type: Treatment
Study Phase: 2
Status: Recruiting
Enrollment: 200
Start: 3/21/2020
Finish: 3/21/2021

NCT04305457: Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19
Study Type: Treatment
Study Phase: 2
Status: Recruiting
Enrollment: 240
Start: 3/21/2020
Finish: 4/1/2021

NCT04280588: Fingolimod in COVID-19
Study Type: Treatment
Study Phase: 2
Status: Recruiting
Enrollment: 30
Start: 2/22/2020
Finish: 7/1/2020

NCT04288102: Treatment With Mesenchymal Stem Cells for Severe Corona Virus Disease 2019(COVID-19)
Study Type: Treatment
Study Phase: 2
Status: Recruiting
Enrollment: 90
Start: 3/5/2020
Finish: 7/15/2020

NCT04273529: The Efficacy and Safety of Thalidomide in the Adjuvant Treatment of Moderate New Coronavirus (COVID-19) Pneumonia
Study Type: Treatment
Study Phase: 2
Status: Not yet recruiting
Enrollment: 100
Start: 2/20/2020
Finish: 5/30/2020

NCT04269525: Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia
Study Type: Treatment
Study Phase: 2
Status: Recruiting
Enrollment: 10
Start: 2/6/2020
Finish: 4/30/2020

NCT04273581: The Efficacy and Safety of Thalidomide Combined With Low-dose Hormones in the Treatment of Severe COVID-19
Study Type: Treatment
Study Phase: 2
Status: Not yet recruiting
Enrollment: 40
Start: 2/18/2020
Finish: 4/30/2020

NCT04264533: Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia
Study Type: Treatment
Study Phase: 2
Status: Recruiting
Enrollment: 140
Start: 2/14/2020
Finish: 9/30/2020

NCT04321993: Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients
Study Type: Treatment
Study Phase: 2
Status: Not yet recruiting
Enrollment: 1000
Start: 4/1/2020
Finish: 2/1/2021

NCT04323527: Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2
Study Type: Treatment
Study Phase: 2
Status: Recruiting
Enrollment: 440
Start: 3/23/2020
Finish: 8/31/2020

NCT04341389: A Phase II Clinical Trial to Evaluate the Recombinant Novel Coronavirus Vaccine (Adenovirus Vector)
Study Type: Vaccine
Study Phase: 2
Status: Not yet recruiting
Enrollment: 500
Start: 4/12/2020
Finish: 1/31/2021

NCT04334044: Treatment of SARS Caused by COVID-19 With Ruxolitinib
Study Type: Treatment
Study Phase: 1|2
Status: Not yet recruiting
Enrollment: 20
Start: 4/1/2020
Finish: 6/1/2020

NCT04333368: Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS
Study Type: Treatment
Study Phase: 1|2
Status: Not yet recruiting
Enrollment: 60
Start: 4/1/2020
Finish: 6/30/2020

NCT04321096: The Impact of Camostat Mesilate on COVID-19 Infection
Study Type: Treatment
Study Phase: 1|2
Status: Recruiting
Enrollment: 180
Start: 3/31/2020
Finish: 12/31/2020

NCT04324606: A Study of a Candidate COVID-19 Vaccine (COV001)
Study Type: Vaccine
Study Phase: 1|2
Status: Not yet recruiting
Enrollment: 510
Start: 4/1/2020
Finish: 5/1/2021

NCT04276896: Immunity and Safety of Covid-19 Synthetic Minigene Vaccine
Study Type: Vaccine
Study Phase: 1|2
Status: Recruiting
Enrollment: 100
Start: 3/24/2020
Finish: 7/31/2023

NCT04276987: A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia
Study Type: Treatment
Study Phase: 1
Status: Not yet recruiting
Enrollment: 30
Start: 2/15/2020
Finish: 5/31/2020

NCT04252118: Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With 2019 Novel Coronavirus
Study Type: Treatment
Study Phase: 1
Status: Recruiting
Enrollment: 20
Start: 1/27/2020
Finish: 12/1/2020

NCT04280224: NK Cells Treatment for Novel Coronavirus Pneumonia
Study Type: Treatment
Study Phase: 1
Status: Recruiting
Enrollment: 30
Start: 2/20/2020
Finish: 9/30/2020

NCT04293887: Efficacy and Safety of IFN-α2β in the Treatment of Novel Coronavirus Patients
Study Type: Treatment
Study Phase: 1
Status: Not yet recruiting
Enrollment: 328
Start: 3/1/2020
Finish: 5/30/2020

NCT04302519: Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells
Study Type: Treatment
Study Phase: 1
Status: Not yet recruiting
Enrollment: 24
Start: 3/5/2020
Finish: 6/30/2021

NCT04313127: A Phase I Clinical Trial in 18-60 Adults
Study Type: Vaccine
Study Phase: 1
Status: Active, not recruiting
Enrollment: 108
Start: 3/16/2020
Finish: 12/30/2020

NCT04299724: Safety and Immunity of Covid-19 aAPC Vaccine
Study Type: Vaccine
Study Phase: 1
Status: Recruiting
Enrollment: 100
Start: 2/15/2020
Finish: 7/31/2023

NCT04326387: Evaluation of Novel Diagnostic Tests for COVID-19
Study Type: Diagnostic
Study Phase: Not provided
Status: Recruiting
Enrollment: 200
Start: 4/6/2020
Finish: 4/7/2021

NCT04322487: Simple, Safe, Same: Lung Ultrasound for COVID-19
Study Type: Diagnostic
Study Phase: Not provided
Status: Not yet recruiting
Enrollment: 100
Start: 4/1/2020
Finish: 12/31/2020

NCT04245631: Development of a Simple, Fast and Portable Recombinase Aided Amplification Assay for 2019-nCoV
Study Type: Diagnostic
Study Phase: Not provided
Status: Recruiting
Enrollment: 50
Start: 1/1/2020
Finish: 12/31/2020

NCT04337489: Remote Monitoring Use In Cases Of Suspected COVID-19 (Coronavirus)
Study Type: Observation
Study Phase: Not provided
Status: Not yet recruiting
Enrollment: 200
Start: 4/1/2020
Finish: 4/1/2021

NCT04330599: Longitudinal Population-based Observation Study of Coronavirus Disease in the UK Population
Study Type: Observation
Study Phase: Not provided
Status: Not yet recruiting
Enrollment: 12000
Start: 4/2/2020
Finish: 4/1/2025

NCT04323644: Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg)
Study Type: Observation
Study Phase: Not provided
Status: Not yet recruiting
Enrollment: 1000
Start: 3/31/2020
Finish: 9/30/2020

NCT04318314: COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2
Study Type: Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 400
Start: 3/18/2020
Finish: 12/31/2020

NCT04319211: Effects of Social Isolation From Coronavirus; on Physical Activity, Quality of Life and Stress
Study Type: Observation
Study Phase: Not provided
Status: Not yet recruiting
Enrollment: 200
Start: 3/25/2020
Finish: 5/15/2020

NCT04336787: Physical Activity Level, Stress Level, Sleep Quality in Covid-19 Quarantine
Study Type: Observation
Study Phase: Not provided
Status: Not yet recruiting
Enrollment: 100
Start: 4/10/2020
Finish: 5/10/2020

NCT04326725: Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 Pandemia
Study Type: Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 80
Start: 3/20/2020
Finish: 7/1/2020

NCT04339491: Physical Activity During Social Isolation
Study Type: Observation
Study Phase: Not provided
Status: Not yet recruiting
Enrollment: 500
Start: 4/1/2020
Finish: 6/1/2020

NCT04319172: Multicentric Study of Coronavirus Disease 2019 (COVID-2019) in Solid Organ Transplant Recipients
Study Type: Observation
Study Phase: Not provided
Status: Not yet recruiting
Enrollment: 50
Start: 3/1/2020
Finish: 3/1/2022

NCT04326400: Active Monitoring And Determinants of Incidence Infection of COVDI-19
Study Type: Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 1000
Start: 3/23/2020
Finish: 7/20/2020

NCT04320732: Risk Factors for Community- and Workplace Transmission of COVID-19
Study Type: Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 50000
Start: 3/27/2020
Finish: 3/27/2022

NCT04314232: Mechanisms to Morbidity and Mortality for Covid-19
Study Type: Observation
Study Phase: Not provided
Status: Not yet recruiting
Enrollment: 200
Start: 3/23/2020
Finish: 12/31/2021

NCT04325412: Cardiac complicAtions in Patients With SARS Corona vIrus 2 regisTrY
Study Type: Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 1000
Start: 3/23/2020
Finish: 3/23/2021

NCT04336345: Outcomes of Patients With COVID-19 in the Intensive Care Unit
Study Type: Observation
Study Phase: Not provided
Status: Not yet recruiting
Enrollment: 150
Start: 4/1/2020
Finish: 4/30/2020

NCT04322513: Biomarkers for Identification of SARS-COV-2 Infection
Study Type: Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 110
Start: 3/24/2020
Finish: 6/30/2020

NCT04307459: Acute Respiratory Failure and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Real Life
Study Type: Observation
Study Phase: Not provided
Status: Not yet recruiting
Enrollment: 50
Start: 3/19/2020
Finish: 4/19/2020

NCT04318366: COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor
Study Type: Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 1000
Start: 3/19/2020
Finish: 3/19/2022

NCT04315870: Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy: The Italian Registry on Coronavirus in Pregnancy.
Study Type: Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 20
Start: 1/1/2020
Finish: 4/20/2020

NCT04324866: Prevalence and Incidence of COVID-19 Infection in Patients With Chronic Plaque Psoriasis on Immunosuppressant Therapy
Study Type: Observation
Study Phase: Not provided
Status: Not yet recruiting
Enrollment: 300
Start: 4/1/2020
Finish: 11/1/2020

NCT04319016: Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy
Study Type: Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 20
Start: 1/1/2020
Finish: 4/30/2020

NCT04322188: An Observation Case-control Study of the Use of Siltuximab in ARDS Patients Diagnosed With COVID-19 Infection
Study Type: Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 50
Start: 3/19/2020
Finish: 5/19/2020

NCT04325048: Clinical Evaluation of Cordio Application in Adult COVID19 Virus Positive Patients
Study Type: Observation
Study Phase: Not provided
Status: Not yet recruiting
Enrollment: 5000
Start: 4/1/2020
Finish: 6/1/2021

NCT04338672: The Impact of the Covid-19 Outbreak on Emergency Room Attendances of Surgical Patients
Study Type: Observation
Study Phase: Not provided
Status: Not yet recruiting
Enrollment: 1000000
Start: 4/5/2020
Finish: 4/1/2021

NCT04325919: Coronavirus Disease 2019 (COVID-19) Study of Hospitalized Patients in Hong Kong
Study Type: Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 170
Start: 2/24/2020
Finish: 2/28/2021

NCT04331106: Survey of the Anxiety Associated With the SARS-CoV-2 Pandemic
Study Type: Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 5000
Start: 3/27/2020
Finish: 9/1/2020

NCT04259892: Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection
Study Type: Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 300
Start: 2/4/2020
Finish: 10/4/2020

NCT04322279: Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection (CoV-CONTACT-SERO)
Study Type: Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 300
Start: 3/9/2020
Finish: 5/1/2020

NCT04324736: "Coronavirus SARS-CoV2 and Diabetes Outcomes"
Study Type: Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 1000
Start: 3/10/2020
Finish: 4/10/2020

NCT04333849: Telephony Or Videophony for Isolated elDerly in Maine-Et-Loire 49 During COVID-19
Study Type: Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 100
Start: 3/27/2020
Finish: 9/1/2020

NCT04314817: Adverse Events Related to Treatments Used Against Coronavirus Disease 2019
Study Type: Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 1000
Start: 3/17/2020
Finish: 1/1/2021

NCT04262921: Clinical Characterisation Protocol for Severe Emerging Infections
Study Type: Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 500
Start: 2/7/2020
Finish: 8/7/2020

NCT04324047: Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients
Study Type: Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 1000
Start: 3/27/2020
Finish: 3/27/2021

NCT04338100: Point Of Care UltraSonography for Risk-stratification of COVID-19 Patients
Study Type: Observation
Study Phase: Not provided
Status: Not yet recruiting
Enrollment: 300
Start: 4/6/2020
Finish: 12/29/2020

NCT04341792: Predictive Biomarkers of Secondary Aggravation in Covid-19 Suspect Patient
Study Type: Observation
Study Phase: Not provided
Status: Not yet recruiting
Enrollment: 1000
Start: 4/1/2020
Finish: 8/1/2020

NCT04341519: Psychological Burden in ICU Survivors of Severe COVID-19 Pneumonia, Their Relatives and Their Healthcare Providers
Study Type: Observation
Study Phase: Not provided
Status: Not yet recruiting
Enrollment: 1464
Start: 4/9/2020
Finish: 11/30/2020

NCT04340466: French Multicentre Observation Study on SARS-Cov-2 Infections (COVID-19) ICU Management Study
Study Type: Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 220
Start: 4/3/2020
Finish: 6/30/2020

NCT04336761: Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France
Study Type: Observation
Study Phase: Not provided
Status: Not yet recruiting
Enrollment: 914
Start: 4/1/2020
Finish: 12/1/2020

NCT04332016: COVID-19 Biological Samples Collection
Study Type: Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 2000
Start: 4/2/2020
Finish: 3/1/2023

NCT04341766: Evolution of Pulmonary Ultrasound in Patients Hospitalized for Covid (Coronavirus Disease) 19
Study Type: Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 200
Start: 3/31/2020
Finish: 5/1/2020

NCT04321265: Outcomes and Prognostic Factors in COVID-19
Study Type: Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 4000
Start: 3/19/2020
Finish: 9/1/2020

NCT04327180: PREdiction of DIagnosed Covid-19 infecTion in IUC Patients
Study Type: Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 500
Start: 3/30/2020
Finish: 9/1/2021

NCT04325646: Sero-epidemiological Study of the SARS-CoV-2 Virus in France: Constitution of a Collection of Human Biological Samples
Study Type: Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 1000
Start: 3/13/2020
Finish: 2/28/2021

NCT04337983: Hemodynamic Characteristics of Patients With SARS-CoV-2
Study Type: Observation
Study Phase: Not provided
Status: Not yet recruiting
Enrollment: 200
Start: 4/15/2020
Finish: 10/1/2020

NCT04320017: Joint Use of Electrocardiogram and Transthoracic Echocardiography in an Observation Study to Monitor Cardio-vascular Events in Patients Diagnosed With COVID-19
Study Type: Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 500
Start: 3/20/2020
Finish: 5/20/2020

NCT04308187: Influence of the COvid-19 Epidemic on STRESS
Study Type: Observation
Study Phase: Not provided
Status: Not yet recruiting
Enrollment: 50000
Start: 3/11/2020
Finish: 3/1/2022

NCT04339322: Characteristics and Outcome of Coronavirus Disease 2019 (COVID-19) in Egypt
Study Type: Observation
Study Phase: Not provided
Status: Not yet recruiting
Enrollment: 200
Start: 5/1/2020
Finish: 7/30/2020

NCT04317365: Awareness Between Pregnant Women Regarding Corona
Study Type: Observation
Study Phase: Not provided
Status: Not yet recruiting
Enrollment: 200
Start: 3/24/2020
Finish: 4/27/2020

NCT04319315: Social Media Effect on Knowledge Dissemination During COVID-19 Virus Outbreak
Study Type: Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 400
Start: 3/11/2020
Finish: 4/1/2020

NCT04339842: Eating Habits of Adults During the Quarantine
Study Type: Observation
Study Phase: Not provided
Status: Not yet recruiting
Enrollment: 400
Start: 4/10/2020
Finish: 5/31/2020

NCT04274322: Identifying Critically-ill Patients With COVID-19 Who Will Benefit Most From Nutrition Support Therapy: Validation of the NUTRIC Nutritional Risk Assessment Tool
Study Type: Observation
Study Phase: Not provided
Status: Active, not recruiting
Enrollment: 117
Start: 2/19/2020
Finish: 4/4/2020

NCT04279795: Detection of 2019 Novel Coronavirus in Multiple Organ System and Its Relationship With Clinical Manifestations
Study Type: Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 20
Start: 1/20/2020
Finish: 1/31/2021

NCT04279782: Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection
Study Type: Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 100
Start: 1/20/2020
Finish: 1/31/2021

NCT04292327: Clinical Progressive Characteristics and Treatment Effects of 2019-novel Coronavirus
Study Type: Observation
Study Phase: Not provided
Status: Active, not recruiting
Enrollment: 400
Start: 1/1/2020
Finish: 4/30/2020

NCT04283396: Study for Novel Coronavirus Pneumonia (NCP)
Study Type: Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 2000
Start: 2/21/2020
Finish: 5/30/2020

NCT04314271: The Observation Study of Cardiac and Pulmonary Ultrasound and Evaluation of Treatment of Severe Patients With Novel Coronavirus Pneumonia
Study Type: Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 80
Start: 3/20/2020
Finish: 5/1/2020

NCT04292340: Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19
Study Type: Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 15
Start: 2/1/2020
Finish: 7/31/2020

NCT04328454: Clinical Characteristics and Prognostic Factors of Patients With COVID-19
Study Type: Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 120
Start: 1/30/2020
Finish: 4/2/2020

NCT04312100: Sequential Oxygen Therapy Strategy for Patients With COVID-19
Study Type: Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 30
Start: 2/1/2020
Finish: 10/1/2020

NCT04311398: Development and Verification of a New Coronavirus Multiplex Nucleic Acid Detection System
Study Type: Observation
Study Phase: Not provided
Status: Not yet recruiting
Enrollment: 100
Start: 3/14/2020
Finish: 6/1/2020

NCT04337502: Clinical and Radiomic Model of COVID-19
Study Type: Observation
Study Phase: Not provided
Status: Completed
Enrollment: 300
Start: 12/23/2019
Finish: 1/20/2020

NCT04255940: 2019-nCoV Outbreak and Cardiovascular Diseases
Study Type: Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 12000
Start: 1/20/2020
Finish: 4/30/2020

NCT04256395: Efficacy of a Self-test and Self-alert Mobile Applet in Detecting Susceptible Infection of COVID-19
Study Type: Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 300000
Start: 2/1/2020
Finish: 7/31/2020

NCT04327570: In-depth Immunological Investigation of COVID-19.
Study Type: Observation
Study Phase: Not provided
Status: Not yet recruiting
Enrollment: 100
Start: 3/27/2020
Finish: 9/30/2020

NCT04305574: Social Media Use During COVID-19
Study Type: Observation (not really health related)
Study Phase: Not provided
Status: Recruiting
Enrollment: 5000
Start: 3/8/2020
Finish: 5/31/2020

NCT04260308: A Survey of Psychological Status of Medical Workers and Residents in the Context of 2019 Novel Coronavirus Pneumonia
Study Type: Psych Observation
Study Phase: Not provided
Status: Recruiting
Enrollment: 30000
Start: 2/3/2020
Finish: 4/15/2020

NCT04299711: Mental Health and Its Correlates Among Chinese Adolescents Exposed to the Novel Coronavirus Disease 2019
Study Type: Psych Treatment
Study Phase: Not provided
Status: Not yet recruiting
Enrollment: 3428
Start: 10/15/2020
Finish: 11/15/2020

More from Op-Med